Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
Technology
Resources
- What’s New
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

May 04, 2022

Personalis Reports First Quarter 2022 Financial Results

Apr 28, 2022

Personalis to Present at Upcoming Investor Conferences

Apr 26, 2022

Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma

Apr 21, 2022

Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales

Apr 20, 2022

Personalis to Announce First Quarter 2022 Financial Results

Apr 12, 2022

Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene

Apr 12, 2022

Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform

Apr 11, 2022

Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022

Mar 31, 2022

Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference

Mar 24, 2022

Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 17

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2022 Personalis Inc. All rights reserved.